Evidence map›Paper›PMID 25422432›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2014

Molecular architecture of the αβ T cell receptor-CD3 complex.

Michael E Birnbaum, Richard Berry, Yu-Shan Hsiao, Zhenjun Chen, Miguel A Shingu-Vazquez, Xiaoling Yu, Deepa Waghray, Suzanne Fischer, James McCluskey, Jamie Rossjohn and 2 more

Open access · bronzeAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 84 papers.

0numbers the graph read from it
0cells of the map it votes in
84citing papers in PubMed
3.9field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

84 citing papers in PubMed, 123 citations in OpenAlex.

  1. Review
  2. Article
  3. Strategies to eliminate native T cell receptors for adoptive T cell therapies.Molecular therapy : the journal of the American Society of Gene Therapy · 2026
    Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Review
  13. Article
  14. Article
  15. Review
  16. Review
  17. Article
  18. Review
  19. Review
  20. Article

24 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 6 institutions in 3 countries.

Michael E BirnbaumDepartments of Molecular and Cellular Physiology and Structural Biology, Stanford University School of Medicine, Stanford University, Stanford, CA 94305; Program in Immunology, Stanford University School of Medicine, Stanford University, Stanford, CA 94305;
Richard BerryDepartment of Biochemistry and Molecular Biology, School of Biomedical Sciences, Monash University, Clayton, VIC 3800, Australia;
Yu-Shan HsiaoDepartment of Cell Biology, Harvard Medical School, Boston, MA 02115;
Zhenjun ChenDepartment of Microbiology and Immunology, Peter Doherty Institute for Infection and Immunity, University of Melbourne, Parkville, VIC 3010, Australia;
Miguel A Shingu-VazquezDepartment of Biochemistry and Molecular Biology, School of Biomedical Sciences, Monash University, Clayton, VIC 3800, Australia; Australian Research Council Centre of Excellence in Advanced Molecular Imaging, Monash University, Clayton, VIC 3800, Australia;
Xiaoling YuDepartment of Cell Biology, Harvard Medical School, Boston, MA 02115;
Deepa WaghrayDepartments of Molecular and Cellular Physiology and Structural Biology, Stanford University School of Medicine, Stanford University, Stanford, CA 94305;
Suzanne FischerDepartments of Molecular and Cellular Physiology and Structural Biology, Stanford University School of Medicine, Stanford University, Stanford, CA 94305;
James McCluskeyDepartment of Microbiology and Immunology, Peter Doherty Institute for Infection and Immunity, University of Melbourne, Parkville, VIC 3010, Australia;
Jamie RossjohnDepartment of Biochemistry and Molecular Biology, School of Biomedical Sciences, Monash University, Clayton, VIC 3800, Australia; Australian Research Council Centre of Excellence in Advanced Molecular Imaging, Monash University, Clayton, VIC 3800, Australia; Institute of Infection and Immunity, Cardiff University, School of Medicine, Heath Park, Cardiff CF14 4XN, United Kingdom; jamie.rossjohn@monash.edu twalz@hms.harvard.edu kcgarcia@stanford.edu.
Thomas WalzDepartment of Cell Biology, Harvard Medical School, Boston, MA 02115; The Howard Hughes Medical Institute, Harvard Medical School, Boston, MA 02115; and jamie.rossjohn@monash.edu twalz@hms.harvard.edu kcgarcia@stanford.edu.
K Christopher GarciaDepartments of Molecular and Cellular Physiology and Structural Biology, Stanford University School of Medicine, Stanford University, Stanford, CA 94305; Program in Immunology, Stanford University School of Medicine, Stanford University, Stanford, CA 94305; The Howard Hughes Medical Institute, Stanford University School of Medicine, Stanford, CA 94305 jamie.rossjohn@monash.edu twalz@hms.harvard.edu kcgarcia@stanford.edu.
Stanford University · USHarvard University · USPeter Doherty Institute · AUAustralian Research Council · AUCardiff University · GBMonash University · AU

Funding

Structural correlates of T cell receptor signalingR01AI103867 · NIAID · STANFORD UNIVERSITY · PI Kenan Christopher GARCIA · 2014 to 2026
$5.3M
Howard Hughes Medical InstituteNIAID NIH HHS R01 AI03867NIAID NIH HHS R01 AI103867
6 · The paper itself

Abstract

αβ T-cell receptor (TCR) activation plays a crucial role for T-cell function. However, the TCR itself does not possess signaling domains. Instead, the TCR is noncovalently coupled to a conserved multisubunit signaling apparatus, the CD3 complex, that comprises the CD3εγ, CD3εδ, and CD3ζζ dimers. How antigen ligation by the TCR triggers CD3 activation and what structural role the CD3 extracellular domains (ECDs) play in the assembled TCR-CD3 complex remain unclear. Here, we use two complementary structural approaches to gain insight into the overall organization of the TCR-CD3 complex. Small-angle X-ray scattering of the soluble TCR-CD3εδ complex reveals the CD3εδ ECDs to sit underneath the TCR α-chain. The observed arrangement is consistent with EM images of the entire TCR-CD3 integral membrane complex, in which the CD3εδ and CD3εγ subunits were situated underneath the TCR α-chain and TCR β-chain, respectively. Interestingly, the TCR-CD3 transmembrane complex bound to peptide-MHC is a dimer in which two TCRs project outward from a central core composed of the CD3 ECDs and the TCR and CD3 transmembrane domains. This arrangement suggests a potential ligand-dependent dimerization mechanism for TCR signaling. Collectively, our data advance our understanding of the molecular organization of the TCR-CD3 complex, and provides a conceptual framework for the TCR activation mechanism.

Indexed as

Amino Acid MotifsAntigensCell MembraneHEK293 CellsHumansLigandsMicroscopy, ElectronModels, MolecularPeptidesProtein MultimerizationProtein Structure, TertiaryReceptor-CD3 Complex, Antigen, T-CellReceptors, Antigen, T-Cell, alpha-betaScattering, RadiationSignal TransductionT-LymphocytesAntigensLigandsPeptidesReceptor-CD3 Complex, Antigen, T-CellReceptors, Antigen, T-Cell, alpha-betaelectron microscopysmall-angle X-ray scatteringT-cell receptor

Identifiers

PMID25422432
PMCPMC4267357
OpenAlexW2000195307

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.